Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/21383284

J. Clin. Oncol. 2011 Apr 1 29 10 1261-70

Download in:

View as

General Info

PMID
21383284